Adar Poonawalla Plans To Produce Million Doses Of COVID-19 Vaccine In Over 3 Months

Jharkhand: Adar Poonawalla, the CEO of Serum Institute of India, has said that his company plans to make millions of doses of COVID-19 Vaccine in a period of over three months, The Indian Express reported.

Serum Institute of India Pvt Ltd is the world’s largest vaccine manufacturer and has partnered with AstraZeneca, a British-Swedish company to manufacture the vaccine.

Poonawalla has said that it will take a long time before everyone gets a vaccine that would be the best alternative of all the possible vaccines in line for treating COVID-19.

Serum Institute has invested hundreds of millions of dollars with AstraZeneca to come up with a suitable vaccine, the announcement of which will be made in a few days. According to The Indian Express report, AstraZeneca’s vaccine has already conducted phase 1 tests.

Poonawlla also hinted that after getting the manufacturing license for the vaccine, his company will produce the same in large quantities. Moreover, the company has also committed millions of dollars in Capex and Opex to produce the vaccine.

About the company’s TB vaccine, VPM BCG, Poonawalla said that the vaccine has already been tested on more than 1000 patients. In two months’ time it will be known whether the vaccine reduces the severity of coronavirus or not.

Serum Institute has also developed a vaccine for pneumonia called ‘pneumococcal vaccine’. Pneumonia is a leading cause of death among children worldwide.